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Abstract: Endophytic fungi have been explored not just for their ecological functions but also for their 
secondary metabolites as a new source of these pharmacologically active natural products. Accordingly, many 
structurally unique and biologically active compounds have been obtained from the cultures of endophytic 
fungi. Fusarium sp. and Lasiodiplodia theobromae were isolated from the root and stem of the mangrove 
plant Avicennia lanata, respectively, collected from Terengganu, Malaysia. High-resolution mass 
spectrometry and NMR spectroscopy were used as metabolomics profiling tools to identify and optimize the 
production of bioactive secondary metabolites in both strains at different growth stages and culture media. 
The spectral data was processed by utilizing a quantitative expression analysis software, the modified Mzmine 
2.10, an in house MS-Excel macro coupled with Antimarin (Antibase and Marinlit) and Dictionary of Natural 
Products databases for dereplication studies. The investigation for the potential bioactive metabolites from a 
15-day rice culture of Fusarium sp. yielded four 1,4-naphthoquinone with naphthazarin structures (1-4). On 
the other hand, the endophytic fungus L. theobromae grown on the 15-day solid rice culture produced 
dihydroisocoumarins (5 to 8). All the isolated compounds (1 to 8) showed significant activity against 
Trypanosoma brucei brucei with MIC values of 0.32-12.5 μM. Preliminary cytotoxicity screening against 
normal prostate cells (PNT2A) was also performed. All compounds exhibited low cytotoxicity, with 
compounds 3 and 4 showing the lowest cytotoxicity of only 22.3% and 38.6% of the control values at 100 
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μg/mL, respectively. Structure elucidation of the isolated secondary metabolites was achieved using 2D-NMR 
and HRESI-MS as well as comparison with literature data. 
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Endophytes are defined as microorganisms that live inter- and/or intra-cellular in plant tissues for a short or prolonged period 
without producing any visible disease symptoms [1]. The endophytic fungi also produce different group of compounds to 
promote plant growth and protect the plant from environmental stress or animal predation. For mutualism, these 
microorganisms   receive thriving    space within the host plant [2]. Unique bioactive metabolites produced by endophytes are 
not only advantageous for the plant itself but also possess high potential for new medicines, which will be able to treat certain 
diseases in humans.  They may also be utilized in functional foods.   The first report on mangrove fungi was in 1955 when 
Cribb did an isolation work on mangrove roots from Australia [3].  
Recently, the number of studies on unique and biologically active compounds produced by endophytic fungi especially from 
marine sources has increased due to advances in dereplication and chromatographic methodologies.  
1.1. Dereplication studies 
The dereplication method is a process for screening the known metabolites from the crude extracts before further scale-up or 
isolation work was undertaken, in order to avoid repetitive work that has already been earlier reported in the literature. High-
resolution electrospray ionisation-liquid chromatography-mass spectrometry (HRESI-LCMS) data from both positive and 
negative ionization modes were subjected to dereplication of the secondary metabolites found in the crude extracts. The 
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dereplication process, coupled with databases such as the Dictionary of Natural Products (DNP) and Antimarin, assisted in the 
isolation and purification steps of the bioactive natural product.  
1.2. Metabolomics 
Metabolomics is a technology of integral experimental analysis of metabolites which includes four basic steps: 1) sample 
preparation and extraction, 2) data acquisition (analysis of the extracts), 3) data mining including data processing and 
multivariate analysis and 4) metabolite identification or dereplication [4]. It has been applied in multidisciplinary areas to 
identify and quantify metabolites such as in molecular and cell biology, functional genomics, chemical toxicology, pathology, 
chemical ecology, drug metabolism, disease progression and natural products chemistry of terrestrial plants, marine organisms 
and their associated-microorganisms [5-7]. A pioneer study using the ‘metabolite profiling’ concept was published in the early 
1970s [8, 9] which reported the analysis of steroids derivatives, acids, and neutral and acidic urinary drug metabolites using gas 
chromatography-mass spectrometry (GC-MS). In natural products research, the term ‘metabolite’ refers to a group of small 
molecules with a molecular weight of <1000 Da. These are classified into primary and secondary metabolites. Primary 
metabolites, which include amino acids, lipids and carbohydrates, refer to molecules that are required to support the growth or 
function of an organism via normal metabolic process. Secondary metabolites, including polyphenols, alkaloids, terpenes, 
polyketides and hormones are molecules related to signaling mechanisms for an organism’s defense and survival [10]. Some of 
these compounds possess potent activity in certain targeted biological tests, making them valuable in drug discovery and 
development. Metabolite profiling of the active metabolites in crude extracts of natural sources is supported by dereplication in 
which the novel compounds from the active groups are differentiated from known compounds which have been studied 
previously [11]. Therefore, a comprehensive analysis on different metabolites in complex mixtures can be achieved using 
several alternative methods such as “metabolite (or metabolic) fingerprinting,” “metabolite profiling” and “metabolite target 
analysis”. The term “metabolic” is used mostly in drug research; it is commonly used to describe the metabolic fate of an 
administered drug [12]. Therefore, metabolomics tools were used to accelerate the identification of potential bioactive 
components from the crude extracts. Using metabolomics and bioassay-guided isolation work to search for the bioactive 
secondary metabolites against the protozoan Trypanosomal brucei brucei (T. b. brucei) S427, the organic crude extract of 
endophytic fungi Fusarium sp. afforded four naphthazarin-related naphthoquinones; namely anhydrofusarubin (1), javanicin 
(2), dihydrojavanicin (3), and solaniol (4). The investigation for other potential bioactive compounds from Lasiodiplodia 
theobromae afforded dihydroisocoumarin congeners, which included trans (5) and cis (6) 4,8-dihydroxy-3-methylisochroman-
1-one, 5-hydroxymellein (7) as well as mellein (8) (Figure 1) after a series of chromatographic purification. 
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Figure 1. Compounds isolated from the endophytes of the mangrove plant Avicennia lanata. 
1.3. Multivariate analysis in metabolomics 
The complex data generated from liquid chromatography-mass spectrometry (LC-MS) and nuclear magnetic resonance 
spectroscopy (NMR) were subjected to statistical multivariate analysis (MVA) to extract the greatest amounts of useful 
information from the data. A basic unsupervised principal component analysis (PCA) was used as the first step for MVA to 
reduce data dimensionality while retaining data quality, followed by different supervised MVA models depending on the 
specific data quality and research objectives [13]. In PCA, major sample components were structured to represent data variance 
in a two or three-dimensional coordinate scheme. This approach disclosed the grouping model of samples and visualized the 
discriminant outliers which may indicate potential novel bioactive natural products which can be targeted for subsequent 
analysis [14]. One of the broadly used supervised MVA was partial least squares (PLS); it related a data matrix containing 
independent variables from samples, such as spectral intensity values (an X matrix) to a matrix containing dependent variables 
(e.g. measurements of response, such as toxicity scores) for those samples (a Y matrix) [15]. OPLS was also combined with 
discriminant analysis (DA) to establish the optimal position to place a discriminant surface which best separated the classes. In 
the final step of the metabolomics approach, the selected unique biomarkers were interpreted to putatively identify the bioactive 
metabolites using databases like DNP and Antimarin.  
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1.4 Human African trypanosomiasis 
Natural products research has an important role in the discovery of various biologically active substances of natural origin for 
potential new drugs. Human African trypanosomiasis is a neglected disease that requires international efforts in the 
development of new potential alternative drugs. Many of the affected rural populations have limited access to appropriate 
healthcare, and the production of anti-trypanosomal drugs is costly. Moreover, the available drugs used for the treatment of 
trypanosomiasis depend on the sub-species of the trypanosomes as well as the stage of the disease. The requirement for drugs 
that are able to cross the blood brain barrier to get into contact with the parasites is also a major challenge in drug design, hence 
some drugs are difficult to administer, are toxic, and cause adverse drug reactions [16, 17]. The current situation necessitates 
the development of new, effective, cheap and safe remedies to combat the trypanosomiasis. Even now, there are no drugs of 
natural origin available commercially that can treat the disease. However, society has typically relied on traditional medicine 
from natural sources to heal a wide range of diseases [18-20] and indeed, previous studies on naphthoquinone metabolites 
which have been isolated from several plant sources have revealed promising anti-trypanosomal activity [21-23]. This has 
driven us to intensify our search for potential anti-trypanosomal agents from natural sources.  
In this phytochemical study, a metabolomics approach was used to target the anti-trypanosomal active secondary metabolites as 
well as in preliminary screening the production of these target metabolites by the plant’s endophytic fungi. The main aims in 
the present work were to isolate secondary metabolites for anti-trypanosomal derived drugs from the endophytic fungi from 
Avicennia. lanata by utilizing metabolomics and bioassays-guided approaches to aid in the preliminary screening, fractionation 
and purification of the targeted bioactive compounds. Eight pure fungal strains were successfully isolated from the fresh root 
and stem of the mangrove plant A. lanata. Rendering the bioactivities of the fungal extracts against T.b. brucei, two strains 
were further chosen for further isolation and chemical work. The objective of this study is to establish a metabolomics approach 
to target and pinpoint the bioactive secondary metabolites directly from the crude or initial chromatographic fractions, 
subsequently, averting the expensive and time-consuming bioassay work for every step of the isolation work.    
2. MATERIALS AND METHODS 
Fusarium sp. and Lasiodiplodia theobromae was isolated from the fresh root and stem (10 cm), respectively, of the mangrove 
plant A. lanata collected from Setiu Wetlands, Terengganu, Malaysia. The respective plant parts were packed and kept in a cold 
box and transported to the University of Strathclyde. Upon arrival, the material was washed under running tap water for a few 
minutes and cut into 2 cm x 2 cm segments. The plant tissue was immersed with 70% isopropanol in order to surface sterilize 
6    Current Medicinal Chemistry, 2018 Mazlan  et al.2018 
the exposed external tissue and was rinsed with sterilized distilled water. The leaves were dissected to retrieve thin slices of the 
inner tissue parts, which were laid onto a malt nutrient agar (MA). Duplicate plates were prepared. Control malt nutrient agar 
plate was also prepared as a blank and left opened under microbiological safety cabinet BioMAT2 (Medical Air Technology, 
UK) during the seeding process. The plates were incubated at 27 + 2 °C (Vindon Scientific Ltd., UK) for 7-15 days. All 
morphologically different colonies were observed and isolated based on the colour of the colony, shape or texture of the 
mycelial pellicle. A 5 mm x 5 mm diameter plug was cut from the edge of the colony and placed in the middle of a new malt 
agar plate to establish a pure colony. The plates were incubated again for 7-15 days. The purity of the single strain was verified 
by visual examination. When colonies were not pure, the isolation step was repeated until a pure colony was achieved. Pure 
strains were re-inoculated and incubated for further taxonomical characterization by molecular biological methods. 
3. EXPERIMENTAL 
3.1 General Experimental Procedures 
Structure determination of the isolated compounds was based on MS and NMR spectroscopy data. One dimensional NMR (1D 
NMR) data consisted of 1H and 13C NMR spectra captured using Jeol (1H 400 MHz, 13C 100.5 MHz, SIPBS, University of 
Strathclyde) and Bruker instruments (1H 600 MHz, 13C 150 MHz, Department of Pure and Applied Chemistry, University of 
Strathclyde) and was confirmed by two dimensional NMR (2D NMR) spectra such as HMQC or HSQC, HMBC, COSY and 
NOESY as well as comparisons with the literature. A pure sample was dissolved in 500 μL of a suitable deuterated solvent and 
transferred to 5 mm Norell NMR tube (Sigma-Aldrich, USA). Samples that were low in quantity were analysed in Shigemi 
tubes (Sigma-Aldrich, USA) with 180 μL of the appropriate deuterated solvent. Dimethyl sulfoxide-d6, chloroform-d, acetone-
d6, and methanol-d3 bought from Sigma-Aldrich (USA) were the deuterated solvents used. The spectra were then processed 
with MestReNova-9.0 (MNova) 2.10 (Mestrelab Research, S.L, Santiago de Compostela, Spain). The optical rotation of 
optically-active compounds was measured with the digital polarimeter 341 (Perkin Elmer, USA) in which the pure compound 
was dissolved in in 2 mL of the suitable solvent (chloroform or acetone) to a concentration of 1 mg/mL. 
3.2 DNA extraction, amplification, sequencing, and strain identification  
The pure fungal strain was successfully isolated from the leaves of mangrove A. lanata and were identified by deoxyribonucleic 
acid (DNA) extraction, PCR amplification and sequencing by using polymerase chain reaction (PCR) with a universal ITS 
primers (Supporting Information; GenBank GQ856236 and GQ856237, respectively). The voucher specimens of all strains 
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were deposited at the Natural Product Metabolomics Laboratory (SIPBS, University of Strathclyde). The strain was chosen for 
further screening and optimized to produce bioactive metabolites using different media. The chemical profile at different 
growth phases was analyzed.   
A small cube (1 cm x 1 cm) of active growing mycelium of the fungus was excised and transferred into a 2 mL of Eppendorf 
tube using a sterile scalpel. 100 μL of extraction solution (Sigma-Aldrich, UK) was subsequently added to the Eppendorf tube 
and briefly vortexed. The disk was thoroughly covered with the extraction solution. The sample was incubated at 95 °C for 10 
mins. Then, 100 μL of dilution solution (Sigma-Aldrich, UK) was added to equal volumes of the extraction solution and 
vortexed to mix. The dissolved sample was stored at 2-8 °C prior to PCR.  
The DNA extract was amplified by polymerase chain reaction (PCR) with a universal ITS primers.  ITS1 was used as a forward 
primer and ITS4 as the reverse primer (Life Technologies, UK). PCR was carried out by using REDExtract-N-Amp PCR 
ReadyMix (Sigma-Aldrich, UK). Into a thin-walled PCR micro-centrifuge tube: 25 μL of REDExtract-N-Amp PCR ReadyMix, 
18 μL of RNA-free water, 3 μL of ITS 1 and ITS 4 primers and 4 μL of fungal DNA were added to a volume of 53 μL. The 
components were mixed gently, centrifuged and the supernatant was collected then applied to the thermal cycler (Perkin Elmer, 
USA) using Genofun/Gfun TD1 PCR cycle. Initial denaturation was set at 95 °C, 15 mins for 1 cycle, followed by denaturation 
for 1 min (35 cycles). The temperature decreased at 56 °C for annealing, 0.5 min (35 cycles), later the temperature increased to 
72 °C at 1 min (35 cycles) for extension. Final extension was continued for 10 mins (1 cycle) and hold at 4 °C prior to 
purification of the PCR products. 
The PCR-amplified DNA was purified on 1% agarose gel using gel electrophoresis at 60 V for 45 minutes in 
Tris/Borate/EDTA (TBE) buffer. The mixture was heated in the microwave for 1 min 30 sec. Water was added until the reading 
was zero, 2 μL of 1% ethidium bromide solution was added as a staining agent. The solution was immediately poured into a gel 
electrophoresis plate and left for 15 min to solidify. The TBE buffer was then added and 15 μL of PCR-amplified DNA 
products were pipetted into the well. The 6 μL DNA ladder was pipetted into the other well as reference. At t=0, the voltage 
was turned down to 150 V and the voltage was increased to 60 V as the gel plate was allowed to run for 45 min. The stained 
DNA fragment was observed under UV camera then sliced from the agarose gel plate and transferred into an Eppendorf tube.  
The PCR-amplified DNA was purified using GenElute Gel Extraction Kit (Sigma-Aldrich, UK). The sliced gel was mixed with 
the Gel Solubilisation solution, incubated at 50-60⁰C for 10 min and vortexed for 2-3 min then mixed with isopropanol and 
centrifuged. The solubilized gel solution was loaded into the binding column and centrifuged for 1 min, discarding the flow-
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through liquid and washed twice then incubated for 1 min at 37 °C followed by centrifugation to elute the product. The 
sequence analysis of the amplicons and the base sequence was performed through GenBank with the aid of the Basic Local 
Alignment Search Tool (BLAST) (http://blast.ncbi.nlm.nih.gov/Blast.cgi) using the ‘BLASTN’ option. Comparison of the base 
sequences with the National Centre for Biotechnology Information (NCBI) database, the best hit [24] confirmed the identities 
of the fungal strains. All fungal sequences were at least 98% identical to the best hit in the NCBI database [25]. The identified 
fungi were Fusarium sp. and Lasiodiplodia theobromae assigned with the accession numbers FJ487927 and KC960898, 
respectively. 
3.4 Dereplication by using HRESI-LCMS 
The dereplication study on the total crude extract and fractions of the samples were performed using HRESI-LCMS, and then 
processed with the MZmine software, an in-house macro coupled with the Dictionary of Natural Products (DNP) 2015 and 
AntiMarin 2012, a combination of Antibase and MarinLit, and SIMCA 14 (Umetrics AB, Umeå, Sweden). The procedure and 
program for HRESI-LCMS was set up as described below. The total crude extract of 1 mg/mL in methanol was analysed on an 
Accela HPLC (Thermo Scientific, UK) coupled with a UV detector at 280 and 360 nm and an Exactive-Orbitrap high-resolution 
mass spectrometer (Thermo Scientific, UK). A methanol blank was also analyzed. The column attached to the HPLC was a 
HiChrom, ACE (Berkshire, UK) C18, 75 mm × 3.0 mm, 5 μm column. The mobile phase consisted of micropore water (A) and 
acetonitrile (B) with 0.1 % formic acid for each solvent. The gradient program started with 10 % B linearly increased to 100 % 
B within 30 mins at a flow rate of 300 μL/min and remained isocratic for 5 min before linearly decreasing back to 10 % B in 1 
min. The column was then re-equilibrated with 10% B for 9 min before the next injection. The total analysis time for each 
sample was 45 mins. The injection volume was 10 μL and the tray temperature was maintained at 12 °C. High-resolution mass 
spectrometry was carried out in both positive and negative ESI ionization switch modes with a spray voltage of 4.5 kV and 
capillary temperature at 320 oC. The mass range was set from m/z 150-1500 for ESI-MS range. 
The mass spectral data was processed using the procedure by MacIntyre et al, which was established in the Natural Products 
Metabolomics Group Laboratory at SIPBS as described here [26, 27]. The LC-MS chromatograms and spectra were viewed 
using Thermo Xcalibur 2.1 or MZmine 2.10. Raw data were initially sliced into negative and positive data sets using the 
MassConvert software package from ProteoWizard (pwiz). The sliced data sets were subsequently exported into MZmine 2.10. 
The spectra were crop-filtered from 4 to 40 mins. The peaks in the samples and solvent and media blanks (where applicable) 
were detected using the chromatogram builder. Mass ion peaks were isolated using a centroid detector threshold that is greater 
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than the noise level set at 1.0E4 using an MS level of 1. The chromatogram builder was used with a minimum time span set at 
0.2 min, and the minimum height and m/z tolerance at 1.0E4 and 0.001 m/z or 5.0 ppm, respectively. Chromatogram 
deconvolution was then performed to detect the individual peaks. The local minimum search algorithm (chromatographic 
threshold: 90 %, search minimum in RT range: 0.4 min, minimum relative height: 5 %, minimum absolute height: 3.0E4, 
minimum ratio of peak top/edge: 2, and peak duration range: 0.3-5 min) was applied. Isotopes were also identified using the 
isotopic peaks grouper (m/z tolerance: 0.001 m/z or 5.0 ppm, retention time tolerance: 0.2 absolute (min), maximum charge: 2, 
and representative isotope: most intense). The retention time normalizer (m/z tolerance: 0.001 m/z or 5.0 ppm, retention time 
tolerance: 5.0 absolute (min), and minimum standard intensity: 5.0E3) was used to reduce inter-batch variation. The peak lists 
were all aligned using the join aligner parameters set at m/z tolerance: 0.001 m/z or 5.0 ppm, weight for m/z: 20, retention time 
tolerance: 5.0 relative (%), weight for RT: 20. Missing peaks were detected using the gap-filling peak finder (intensity 
tolerance: 1.0 %, m/z tolerance: 0.001 m/z or 5.0 ppm, and retention time tolerance of 0.5 absolute (min). An adduct search was 
performed for both negative and positive mode. For ESI negative mode, formate adducts were searched for, (RT tolerance: 0.2 
absolute (min), m/z tolerance: 0.001 m/z or 5.0 ppm, max relative adduct peak height: 30 %). A complex search was also 
performed with ionization method [M-H]-. For ESI positive mode, adducts that were searched included Na+H, K+H, NH4 and 
ACN+H. A complex search was performed with ionization method [M+H]+, retention time tolerance: 0.2 absolute (min), m/z 
tolerance: 0.001 m/z or 5.0 ppm, and with maximum complex peak height of 50 %. The processed data set was then subjected 
to molecular formula prediction and peak identification. The data sets were exported to csv (comma delimited) to be imported 
to the in-house macro workstation. By using the macro, both the negative and positive data sets were imported for preparation 
followed by the removal of all media blanks and the samples. The macro combined all processed data from different media and 
samples and then prepared for the final data set to be imported to SIMCA 14 followed by the dereplication step using the 
Antimarin and DNP databases. The combined data set was imported into SIMCA 14 for multivariate analysis. Pareto scaling 
was applied. PCA and supervised OPLS-DA were used compare the metabolic profiles of different samples and to evaluate 
their unique secondary metabolites. The models were validated by a permutation test. The Y intercept (Q2Y) on the permutation 
graph is a measure to check against overfitting. A clear indication that the model is valid and does not happen by coincidence is 
when the Q2 values of the permuted Y models are less than zero on the permutation plot test. Moreover, the difference between 
Q2 and R2Y must be less than 0.3, indicating the absence of overfitting. 
 
 
10    Current Medicinal Chemistry, 2018 Mazlan  et al.2018 
3.5 Isolation and purification on the bioactive metabolites 
The pure fungal strains were inoculated onto a new agar plate and incubated for 8 days. The agar on which the fungi grew on 
was cut into small cubes and transferred into 40 x 1L containing rice media (100 g of rice: 100 mL of water) or 20 x 2 L of 
Erlenmeyer flasks (200 g of rice: 200 mL of water) which have been autoclaved before use and incubated at room temperature 
for 15 days. The metabolites were extracted twice with equal volumes of ethyl acetate to the aqueous phase, homogenized and 
filtered to give an organic phase which was then concentrated under vacuum rotary evaporator (Büchi, Switzerland) to afford 
the crude extract. The total crude extract was dissolved in any suitable solvent, mixed with Celite S (Sigma-Aldrich, Mexico) 
then fractionated by medium pressure liquid chromatography (Büchi, Switzerland) through gradient elution commencing with 
100% hexane to 100% ethyl acetate for 20 mins, followed by 100% ethyl acetate to 30% ethyl acetate and 70% methanol for 30 
mins at a flow rate of 50 mL/min. A silica column (VersaFlash/Supelco, UK) with dimensions of 4 x 150 mm and a particle 
size of 20-45 μm was used. The fraction collection volume was set at 100 mL/tube.  TLC was carried out to monitor the 
separation profiles of the fractions and similar fractions were pooled together. The pooled fractions were concentrated under 
vacuum by a rotary evaporator to give 16 major fractions and were analyzed using HRESI-MS for dereplication study and 
tested for anti-trypanosomal activity. The active major fractions were subjected to further isolation and purification using 
conventional gravity column or by high-throughput flash chromatography (Grace Reveleris, USA and Biotage Isolera One, 
Sweden) which can be either normal or reverse phase fitted with the respective commercially available pre-packed column 
either from Reveleris USA or SNAP Sweden. The two flash chromatography instruments were used to isolate and purify the 
active fractions or small quantity of the crude extracts. The non-UV active metabolites were purified by using Grace, since dual 
detectors were coupled to the instrument. Whereas, the UV active metabolites were purified by using Biotage, since this 
machine able to detect the UV active compounds in the 200-400 nm range. Open column chromatography was used with 
various column sizes and silica gel 60 (Kieselgel 60), 0.035-0.070 mm (220-440 mesh ASTM) (Alfa Aesar, UK). 
3.5.1 Isolation of secondary metabolites from Fusarium  
Further isolation and purification on the active fractions was carried out, targeted and afforded compounds 1, 2, 3, and 4 that 
contributed to the anti- trypanosomal activity. The active fractions were subjected to different chromatography techniques using 
by high-throughput flash chromatography as well as the conventional gravity column. Purification of fraction 4 yielded violet 
crystals of anhydrofusarubin (1, 7.3 mg). Further isolation on fraction 8 gave red crystals of javanicin (2, 5.7 mg) and fraction 
six gave dihydrojavanicin (3, 2.4 mg). Purification of fraction 11 gave red crystals of solaniol (4, 7.0 mg). 
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3.5.2. Isolation of secondary metabolites from L. theobromae  
The active fractions were subjected to isolation and purification, yielding six pure compounds. Further purification of fraction 
LTRC15-6 and 8 gave (−)-trans-axial-4-hydroxymellein (5, 7.0 mg) and another congener of (−)-cis-equatorial-4-
hydroxymellein (6, 8.7 mg), respectively. Meanwhile, several purifications of fraction LTRC15-8 gave (−)-5-hydroxymellein 
(7, 6.0 mg). Isolation work on fraction LTRC15-3 yielded the colourless crystals of (-)-mellein, (8, 11.0 mg). 
3.6 Bioassays 
MIC assays were performed for samples having greater than 90% inhibition at a concentration of 20 μM in the initial screening 
campaign. The MIC values of the isolated compounds against T. b. brucei were determined by averaging the results of two 
independent assays. The concentrations were averaged and converted to μM.   
Meanwhile, the initial screening for cytotoxicity activity of the isolated compounds was performed on human normal prostatic 
epithelial cells (PNT2A) at 100 μg/mL. The % D of control was determined by averaging the results of three independent 
assays. In the initial screening, if the cell viability is less than 60%, a concentration response test at 0.3 to 300 μg/mL was 
carried on.  
3.6.1 Anti-trypanosomal Assay: 
The activity of the fungal extracts along with its pure compounds were tested in vitro against the blood stream form of 
Trypanosomal brucei brucei (T. b. brucei) S427. The activity of the samples was determined using the well-established Alamar 
blue™ 96-well microplate assay, in which the screening procedure was modified from the microplate Alamar blue assay [28], 
to determine drug sensitivity of African trypanosomes. The samples were initially screened at one concentration (20 μg/mL 
crude extracts or fractions, 20 μM for pure compounds) to determine their in vitro activity. Stock solutions of tested samples in 
DMSO (Fischer Scientific, UK) were prepared at concentrations of 10 mg/mL (extracts) or 10 mM for pure compounds. The 
concentration of DMSO should not exceed 0.5% of the final test solution. The 10 mg/mL stock solutions of the samples were 
diluted 1 in 10 with HMI-9 and 4 μL was pipetted into 96 μL HMI-9 in the 96-well plate. Sterility and DMSO control samples 
were placed in column 1 of the 96-well plates, test samples in columns 2 to 11 and a concentration range of suramin as a 
positive control in column 12. Trypanosomes were counted using a haemocytometer and diluted to a concentration of 3.0 x 104 
trypanosomes per mL, and 100 μL of this suspension was added to each well of the assay plate with the exception of A1 well 
which contained the sterility control. The assay plate was incubated at 37 ºC, 5% CO2 under humidified atmosphere for 48 
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hours. Later, 20 μL of Alamar blue was added and further incubated for 24 hours. Fluorescence was then determined using the 
Wallac Victor 2 microplate reader (Perkin Elmer, Cambridge, UK) (excitation: 530 nm, emission: 590 nm). The results were 
calculated as % of the DMSO control values.  
Minimum inhibitory concentration values (MIC) were determined for pure compounds with less than 10% growth compared to 
the control values. MIC determinations were carried out in duplicate. Test solutions at 200 μg/mL were prepared in column 2 
by pipetting 4 μL of 10 mg/mL test stock solution and 196 μL of HMI-9 medium into each well. 100 μL of HMI-9 medium was 
pipetted into columns 1 and 3 to 12, and serial 1:1 dilutions are carried out using a multi-channel pipette from columns 2 to 11. 
20 μL of x 10 concentration of suramin was added to column 12 (different concentrations, ranging from 0.008 to 1.0 μM). An 
inoculum of 100 μL of trypanosomes at a concentration of 3.0 x 104 per mL was added to each well except A1, and the 
procedure continued as previously described [28] The MIC values were determined as the concentration calculated to have 
growth activity less than 5% of the control values. 
3.6.2 Cytotoxicity Assay: 
The pure compounds from endophytic fungi of mangrove plant A. lanata were tested for cytotoxicity in vitro against human 
normal prostatic epithelial cell line (PNT2A) derived from ECACC (Sigma-Aldrich, Dorset, UK).  
The cytotoxicity activity of the pure compounds was determined using the well-established Alamar Blue™ redox-based 96-well 
microplate assay, in which the screening procedure was modified from [29]. PNT2A cells were seeded into 96-well microplate 
assay at density of 0.5 x 104 cells/well in 100 μL Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen, Paisley, UK) and 
incubated at 37 ºC, 5% CO2 with a humidified atmosphere for 24 hours. The tested compound was prepared at desired 
concentrations in DMEM solutions, while DMSO and Triton X as a negative and positive controls, respectively, were added 
into the microplate to give a total volume of 200 μL. The microplate plate was incubated at 37 ºC, 5% CO2 with a humidified 
atmosphere for 24 hours, then 10 μL of Alamar blue was added. The microplate was further incubated for another 20 hours, 
then the fluorescence was measured using a Wallac Victor 2 microplate reader (Perkin Elmer, Cambridge, UK) (excitation: 530 
nm, emission 590 nm). The results were calculated as % of the DMSO control values. IC50 values of the tested compounds were 
determined using Graph pad prism software. 
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4. RESULTS AND DISCUSSION 
4.1 Dereplication of Small Scale Extracts of Fusarium sp. and L. theobromae  
The OPLS-DA (Figure 2A) scores scatter plot showed the difference between small-scale active extracts (coloured blue) of 
Fusarium sp. (FRC15, FRC30, FLC7, FLC15, and FLC30) and L. theobromae (LTRC15). The inactive extracts (coloured 
green) are FRC7, LTRC7, LTRC30, LTLC7, LTLC15, and LTLC30. Meanwhile, from the S-loadings scatter plot (Figure 2B), 
metabolites can be predicted to be responsible for the anti-trypanosomal activity of the extract and be targeted for isolation 
work. From the Fusarium extracts, two discriminating metabolites found were at m/z 293.103 [M−H]− and 286.071 [M+H]+, 
both of which gave a match from the database. The ion peak at m/z 286.071 [M+H]+ was putatively identified as bostrycoidin 
previously isolated from Fusarium solani, F oxysporum, F. decemcellulare,  F. bostrycoides, and F. solani. While the ion peak 
at m/z 293.103 [M−H]− matched with 7-O-demethylmonocerin earlier reported from F. larvarum. For L. theobromae bioactive 
extracts, the two discriminating metabolites were observed at m/z 337.258 [M+H]+ and 552.392 [M+H]+, which did not find 
any match from the database.  
Table 1A.  Yield and anti-trypanosomal activity of small-scale extracts and fractions (calculated as mean value of percentage viability) at 




T. b. brucei, 
% D control 
FRC7 63.8 94.0 
FRC15 97.4 0.1 
FRC30 103.2 -2.9 
FLC7 24.2 -8.5 
FLC15 72.6 -9.3 




T. b. brucei, 
% D control 
LTRC7 90.1 47.3 
LTRC15 103.4 1.9 
LTRC30 127.8 15.6 
LTLC7 54.5 90.0 
LTLC15 83.6 61.4 
LTLC30 157.2 54.5 
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Figure 2. (A) OPLS-DA scores scatter and (B) S-loadings plot of small-scale extracts of Fusarium sp. and L. theobromae cultures 
(R2(Y) = 0.92; Q2 = 0.576; Q2(Y intercept) from permutation test = −0.714). (C) PCA scores scatter plot (R2 =0.849; Q2 = 0.292) and 
(D) heat map of HRMS data of small-scale extracts of Fusarium sp. and L. theobromae cultures. Highlighted column on heat map 
indicates best fermentation condition in terms of yield and bioactivity. Legend: FLC7 = Fusarium liquid culture-7 days; FLC15 = 
Fusarium liquid culture-15 days; FLC30 = Fusarium liquid culture-30 days; FRC7 = Fusarium rice culture-7 days; FRC15 = 
Fusarium rice culture-15 days; FRC30 = Fusarium rice culture-30 days; LTLC7 = L. theobromae liquid culture-7 days; LTLC15 = L. 
theobromae liquid culture-15 days; LTLC30 = L. theobromae liquid culture-30 days; LTRC7 = L. theobromae rice culture-7 days; 
LTRC15 = L. theobromae rice culture-15 days; LTRC30 = L. theobromae rice culture-30 days. 
 
Amongst the small-scale extracts, cultures from days 15 and 30 for both media were considered for upscaling. The other 
parameters that needed to be considered were the shorter cultivation period and yield of the extract to have enough starting 
material for further isolation work (Table 1). A PCA model (Figure 2C) was also used to examine the variation and the 
diversity of the various extracts.  However, the PCA model gave a low predictability score with Q2 = 0.292. No significant 
variation can differentiate the Fusarium extracts. The differences between the extracts were visualized by using a heat map 
analysis of the HRMS datasets (Figure 2D). Amongst the Fusarium extracts, the fungus grown in 15 days rice cultures afforded 
more chemically diverse metabolites as represented by the blue bars between m/z 250 to 1000 Da, while it yielded less of the 
low molecular weight compounds at 150 to 250 Da.  Interestingly, the 30 days rice culture of L. theobromae, despite of its 
increase in chemical diversity and extract yield, there was a significant loss of bioactivity. Based on the results of the heat map 
analysis of the mass spectral data (Figure 2D) and anti-trypanosomal activity, Fusarium sp. (FRC15) and L. theobromae 
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Figure 3. (A) Total ion chromatogram of the crude extract of Fusarium sp. grown in rice media for 15 days (FRC15) (blue and red 
represent positive and negative ionisation modes, respectively). Dereplication of numbered peaks is shown on Table 3. Boxed in red is 
the isolated compound javanicin.  (B) OPLS-DA scores scatter plot of bioactive vs inactive Fusarium sp. fractions (R2(Y) = 0.998; Q2 = 
0.664; Q2(Y intercept) from permutation test = −0.15). (C) OPLS-DA loadings and (D) S-plot of bioactive vs inactive Fusarium 
metabolites.  Metabolites designated with a star were those similarly observed on the TIC chromatogram as well as those discriminating 
metabolites during the initial fermentation procedure at m/z 293.103 [M-H]− and 286.071 [M+H]+, while those in triangles and with 
boxed m/z represent the isolated compounds Their relative abundance in the active fractions are shown in Figure 4. 
(LTRC15) grown in rice cultures incubated for 15 days were the optimum conditions for the production of the bioactive 
metabolites in these two fungi.  
4.2 Dereplication, multivariate analysis, and isolation of bioactive metabolites of Fusarium sp. extracts and fractions 
The dereplication study on the total crude extract of Fusarium sp. was performed by using the HRESI-LCMS data. The total 
ion chromatogram of the Fusarium sp. crude extract (Figure 3A) showed distribution of known and unknown compounds 
(Tables 2 and 3, respectively) present in FRC15 total extract. Most of the metabolites that gave a match from the database were 
produced from both marine and terrestrial fungi namely: Sclerotinia libertiana, Gibberella fujikuroi, Epidermophyton 
floccosum, Fusarium sp., Aspergillus sp., Basidiomycetes, Pestalotiopsis sp. and Sphaeropsis sapinea (Table 3). The m/z values 
and predicted formulas of unknown metabolites were also listed in Table 2. 
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Table 3. List of compounds indicated on the total ion chromatogram for the crude extract of Fusarium sp. (FRC15) that were putatively identified using the Antimarin database. Highlighted 
rows represent compounds predicted to be anti-trypanosomally active by MVA as indicated with their MZmineIDs.  Peak IDs used in this table correspond to those designated for the 











(ppm) Sources Peak area 
1 N 7.52 233.0819 234.0892 C13H14O4 sclerin -0.1035 
 Sclerotinia libertiana, 
Aspergillus carneus 
1.04E+07 
2 N 8.46 187.0976 188.1049 C9H16O4 isoaspinonene 0.3467 A. ochraceus 8.81E+07 
3 N 9.80 377.1607 378.1680 C20H26O7 gibberellin A13 1.7686  Gibberella fujikuroi 2.14E+07 
4 N 11.17 291.0511 292.0584 C14H12O7 floccosic acid 2.0550  Epidermophyton floccosum 1.20E+07 
5 N_5236 11.95 305.0667 306.2670 C15H14O7 fusarubin 1.8790 
 Fusarium solani,  




6 N_5758 12.59 329.1396 330.3750 C19H22O5 gibberellin A11 1.9675  Gibberella fujikuroi 4.64E+07 




 Chinese truffle  
Tuber indicum 
4.82E+07 
8 P 13.57 275.0910 274.084 C15H14O5 8-deoxyjavanicin 1.7348 F. solani; "Munissi MUF2" 8.60E+07 
9 N_809 14.08 347.1864 348.1937 C20H28O5 LL-S-491g; sphaeropsidin B 1.6057 
 A. chevalierii (Lederle S491),  
 Sphaeropsis sapinea, 
Diplodia mutila, 
2.49E+07 
10 N_5770 14.31 329.0668 330.0741 C17H14O7 bisdechlorogeodin 2.1585 
 A. fumigatus; (+): Penicillium 
 frequentans; (-) Oospora 
sulphurea.  
1.42E+07 
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11 P_2144 14.57 291.0862 290.0789 C15H14O6 javanicin (2)* 1.5075 
F. solani,  
F. decemcellulare  
1.54E+07 
12 N_2478 15.94 333.2073 334.2146 C20H30O4 flexibilide 0.5461 Cnidaria; Sinularia flexibilis 5.09E+07 
13 P_2560 16.02 286.0709 285.0637 C15H11NO5 bostrycoidin 1.7338 
 F. solani, F. oxysporum,  
F. decemcellulare,  
F. bostrycoides,  
F. solani-purple 
9.01E+07 
14 N 16.44 327.2179 328.2251 C18H32O5 SCH-725674 0.5532  Aspergillus sp. 2.46E+07 
15 N 16.82 343.2127 344.2200 C18H32O6 gallicynoic acid F 1.9340 
 Basidiomycete; Coriolopsis 
gallica 
1.61E+07 
16 N 17.20 325.2021 326.2094 C18H30O5 pestalotiopsin B 0.3059 
 Pestalotiopsis sp. (endophytic 
fungus of Taxus brevifolia) 
1.76E+07 
17 N 18.01 347.1995 348.2068 C18H33ClO4 plakortether C 0.0423 Porifera; Plakortis simplex 4.81E+07 
18 N 18.39 307.1917 308.1989 C18H28O4 sorokinianin 0.5743  Bipolaris sorokiniana 1.47E+07 
19 N_499 19.96 295.2278 296.2350 C18H32O3 
(1S,2R)-3-oxo-2-(2Z-(1S,2R)-3-oxo-2-
pentylcyclopentane-1-octanoic acid 
0.3310 F. oxysporum 2.67E+07 
20 N 20.49 311.2228 312.2301 C18H32O4 filoboletic acid 1.7144  Fungus Filoboletus sp. 1.19E+09 
21 N_2820 20.69 297.2435 298.2508 C18H34O3 
D-12-hydroxy-9-octadecenoid acid; 
ricinoleic acid 
0.0901  Ascomycetes, Basidiomycetes 3.63E+07 
22 N 22.07 313.2382 314.2458 C18H34O4 6-hydroxy-4-oxo-octadecanoic acid 0.1789  Hygrophorus discoxanthus 1.87E+08 
23 N 25.54 715.5327 716.5400 C47H72O5 variabilin 5,9-tetracosadienoate 2.8351 Porifera Ircinia felix 6771285 
24 P 27.50 395.2789 394.2724 C23H38O5 15-acetoxyhexadecylcitraconic anhydride 0.7611  A. wentii 1.48E+07 
25 N 28.97 351.1865 352.1937 C18H34Cl2O2 9,10-dichlorostearic acid 1.9680  Verticillium dahliae 2.96E+07 
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(min) MS (m/z ) 
Molecular 
weight Peak area 
N 6.23 151.0400 152.0473 1.54E+07 
P 8.12 164.1071 163.0998 3.85E+07 
N 13.64 929.1953 930.2026 3.72E+07 
N 14.60 923.1485 924.1558 2.60E+07 
N 27.04 349.1709 350.1781 5.79E+07 
 
The bioactivity test results on Fusarium sp. fractions showed that fractions 1 to 3 were inactive while fractions 4 to 12 exhibited 
strong anti-trypanosomal activity. Meanwhile, the OPLS-DA plot (Figure 3B) showed distinctive separation of fractions 
FRC15-10, 15-11 and 15-12 compared with the other bioactive fractions. Their dispersal from the other extracts reflected their 
unique chemical fingerprints. In Figure 3B, a larger sized symbol was used for observation points with DModX values twice as 
large as the DCrit values, as demonstrated by fractions FRC15-10 and 15-12. These extracts were then interpreted as moderate 
outliers. The DModX is the distance of the respective samples to the X plane of the model while DCrit is the critical distance to 
the model computed from the F-distribution to attain a 95% confidence interval limit. In simpler terms, at a significant level of 
0.95, 95% of the observations should have DModX values less than the DCrit value at 1.302 in this model. Dcrit limit was set 
at 0.05. In this model, fractions FRC15-10 and 15-12 were shown to be different from the other extracts with respect to the 
correlation structure of its distinct chemical profile. The unique metabolites were indicated by [M−H]− ion peaks at m/z 
331.155, 659.286, and 329.14, as shown on the OPLS-DA loadings scatter plot (Figure 3C). Dereplication results revealed that 
the ion peak at m/z 331.155 [M−H]− matched with the molecular formula C19H24O5, putatively identified as pestalotiopsone A 
reported from Pestalotiopsis sp. The ion peak at m/z 329.140 [M−H]−was dereplicated as a diterpene commonly found from 
Sinularia soft coral with a molecular formula of C20H24O5. On the other hand, no hit was found for the ion peak at m/z 659.286 
[M−H]−.  
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Further investigation on Fusarium sp. extract FRC15 was carried out by evaluating the occurrence of the metabolites in the 
respective chromatographic fractions, which were correlated with their bioactivity against T. b. brucei (Figures 3C and 3D).  It 
can be observed that not all peaks perceived on the TIC of the crude extracts listed on Table 3 were found on the active side of 
the S-plot. As shown on Figure 3D, metabolites designated with a star were those similarly observed on the TIC chromatogram 
as well as the discriminating metabolites found for the crude extracts at m/z 293.103 [M−H]− (7-O-demethylmonocerin) and 
286.071 [M+H]+ (bostrycoidin), while those in triangles and with boxed m/z values represent the isolated compounds. However, 
the peak signal for m/z 293.103 was not highlighted in the TIC (Figure 3A) due to the overlapping peaks in the crude extract of 
large scale batch. Further fractionation revealed the presence of this metabolite on the S-plot (Figure 3D). The discriminating 
metabolites targeted from the crude extract during the initial fermentation procedure were however not isolated due to their low 
yield in the active fractions. Although these two latter ion peaks were observed with good intensity, their detection was 
dependent on their capability to ionize and does not reflect their “true” concentration in the extract or the fraction. MVA is an 
unbiased approach in detecting the probable bioactive metabolites regardless of their concentrations in a fraction or crude 
 
 
Figure 4. Relative abundance of target metabolites (A-D) and isolated naphthazarin derivatives in the bioactive fractions (E-H). Arrows 
indicate the occurrence of the target metabolites in the segregated fractions FRC15-10 to 12. Asterisk specifies the fraction from where the 
respective compounds were isolated. A) N_809: m/z = 347.186, RT = 14.1 min; B) P_2560: m/z = 286.071, RT = 16.0 min; C) N_5236: m/z 
= 506.067; RT = 11.9 min; D) N_759: m/z = 293.103, RT = 10.3 min; E) N_1099: anhydrofusarubin (1), m/z = 287.056, RT = 18.7 min; F) 
P_2144: javanicin (2), m/z = 291.086, RT = 14.5 min; G) N_3423: dihydrojavanicin (3), m/z = 289.072, RT = 13.8 min; H) N_4899: 
solaniol (4), m/z = 291.087, RT = 13.6 min. 
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extract. The metabolomics approach has an advantage to the conventional way of phytochemical work done in the past where 
compounds were isolated according to their occurrence in a chromatogram. Albeit, very potent metabolites present at ng levels 
were detected, the limitation was the subsequent isolation work at which such low yielding compounds surpassed the limit of 
quantification. However, in this study, the MVA was able to guide the isolation work of the bioactive metabolites, which were 
not detected on the TIC. While mass spectrometry cannot be quantitative when the detection of respective compounds is 
dependent on their ionizing capability, NMR spectroscopy has the advantage of exhibiting the true ratios and a fingerprint of 
mixture metabolites in a crude extract or fraction. The NMR spectra of the active fractions of FRC15 were dominated by 
resonances typical for the naphthazarin derivatives as those of the exchangeable hydrogen bonded hydroxyl units at ca. 12 ppm 
rather than the 8 ppm resonance expected for a methine vicinal to a nitrogen unit in a pyridine system as in bostrycoidin. 
Instead, ion peaks at m/z 289.070 and 291.086 [M+H]+ or 287.056 and 289.086 [M−H]−  were isolated as well as elucidated as 
anhydrofusarubin (1) and javanicin (2), respectively, which have been previously described from Fusarium species, F. 
decemcellulare [30] and F. solani [31]. From the TIC peaks, only peak 11 could be isolated, which was later characterized as 
javanicin (2). Anhydrofusarubin was previously described from the fungus F. solani [32]. Javanicin (2) was earlier isolated 
from F. javanicum [33], another species of Fusarium sp. obtained as an aerial contaminant [34], and from F. solani isolated 
from pollen grain of Pinus thumbergii Parl [32], Chloridium sp.; an endophytic fungus from neem plant [35] and a sea fan-
derived Fusarium [36]. However, in another report [37], the hydroxyl groups were attached at C-1 and C-4, respectively, which 
was proposed as dihydrojavanicin (3). Based on the spectral data and comparison with the literature, this compound was 
elucidated to be dihydrojavanicin (3) found at m/z 289.072 [M−H]− , which had also been derived from the javanicin skeleton 
with a difference in positions of the carbonyl and hydroxyl substituents. However, this compound was also assigned the trivial 
name  javanicin in the literature [37]. The metabolite with an ion peak at m/z 291.087 [M−H]− was recognized as solaniol (4), 
which was earlier isolated from F. solani; "munissi MUF2" [32, 36]. An ion peak at m/z 295.2280 [M-H]- was putatively 
identified as (1S,2S)-3-oxo-2(2Z-pentenyl)cyclopentane-1-octanoic acid which has been previously isolated from F. oxysporum 
[38]. The relative occurrence of the target metabolites and isolated compounds in the bioactive fractions and absence in the 
inactive fractions are shown on Figure 4.   
4.3 Dereplication, multivariate analysis, and isolation of bioactive metabolites of L. theobromae extracts and fractions  
The total ion chromatogram of the crude extract of L. theobromae LTRC15 (Figure 5A) presented the distribution of known and 
unknown compounds (Tables 4 and 5) present in LTRC15 total extract. These compounds were listed in Table 5 and were 
dereplicated using the AntiMarin and DNP database. Several of these identified metabolites were earlier isolated from other 
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endophytic fungi; these include asparvenone from Aspergillus parvulus, 1,3-dihydro-3,7-dihydroxy-5-methoxy-6-methyl-4-
isobenzo-furancarboxylic acid from Aspergillus duricaulis, and viscumamide from Paecilomyces sp. isolated from mangroves. 
Some of the identified metabolites also have been isolated from marine endophytic fungi, bacteria, lichens, chordates, and 
sponges. Meanwhile, the m/z values and predicted formulas of unknown metabolites were listed in Table 4.  
Table 4. Compounds present in the crude extract of L. theobromae (LTRC15) that were unidentified using the Antimarin and DNP database. 
ESI modes Rt (min) MS (m/z) Molecular weight Peak Area 
N 5.48 172.0971 173.1053 2.98E+08 
N 5.97 151.0402 152.0475 4.39E+07 
N 11.92 361.1870 362.1943 8.97E+08 
N 15.57 519.2809 520.2882 1.51E+09 
P 16.18 668.4230 667.4158 2.13E+08 
N 18.54 835.4683 836.4756 3.59E+08 
N 18.90 596.4028 597.4100 4.56E+07 
N 19.84 610.4186 611.4259 5.31E+08 
N 21.11 580.2950 581.3023 2.29E+08 
P 27.90 535.3610 534.3537 1.45E+08 
 
A dereplication study on the L. theobromae fractions was accomplished to investigate the metabolite profile of each fraction 
and its correlation with the bioactivity against T. b. brucei (Figure 5B). The loadings plot (Figure 5C) displayed the 
distribution of metabolites in the various fractions. The ion peaks at m/z 393.316 [M+H]+, putatively identified as 24R-
ergostatetraen-3-one was previously reported from Dysidea herbacea [39], 185.082 [M-H]- was identified as dihydroaspyrone 
from Aspergillus ochraceus [40], and 239.060 [M-H]- identified as coloratin B from Xylaria intracolorata [41]. Ion peaks at 
m/z 193.05 [M−H]− while overlapping on the loadings plots (Figures 5C and D) were identified and represents the isolated 
metabolites 4-hydroxymellein or also known as 4,8-dihydroxy-3-methylisochroman-1-one (5 or 6) and 5-hydroxymellein (7), 
respectively described from Uvaria hamiltonii [42] and Penicillium sp. [43].  Isolated compound 5 was designated as (−)-
trans-axial-4-hydroxymellein. Compound 5 was earlier described by biotransformation of the marine bacterium Stappia sp. 
[44], as well as from the fungi Aspergillus ochraceus, A. oniki, Seimatosporium sp. and an endophytic fungus of the conifer 
tree Canoplea elegantula [45-48], Uvaria hamiltonii [42], Apiospora camptospora [49] and Penicillium sp. [43]. On the other 
hand, a (−)-cis-equatorial-4-hydroxymellein derivative (6) has been previously reported from the fungi L. theobromae [49], A. 
ochraceus, Seimatosporium sp. and the ascidian Eudistoma vannamei [45, 47, 50], Uvaria hamiltonii [42], Cercospora 
taiwanensis [51] and Aspergillus melleus [52, 53]. Seimatosporium sp. [47] was also conveyed to yield (−)-5-hydroxymellein 
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(7). It has also been described from the fungi Septoria nodorum [54] and Botryosphaeria obtuse [55, 56] and Penicillium sp. 
[43]. The identified ion peaks from the OPLS-DA loadings (Figure 5C) and S-plot (Figure 5D) representing the predicted 
bioactive metabolites were not perceivable from the TIC chromatogram shown in Figure 5A. For the similar reason, already 
mentioned above, MVA guided the isolation work of the bioactive metabolites, which were not detected on the TIC.  The 
parent compound (−)-mellein (8) or 8-hydroxy-3-methylisochroman-1-one was also isolated. (−)-Mellein has been reported 
from an endophyte of the coniferous tree Pezicula sp. [57]. This compound was described for the first time from Aspergillus 
melleus [58], and previously reported from Lasiodiplodia theobromae [49], Aspergillus ochraceus, Botryosphaeria obtusa [45, 
56], the mangrove ascomycete Helicascus kanaloanus [59], and a fungus causing the citrus disease, Phoma tracheipilla [60]. 
Mellein and its derivatives were isolated from fractions 3, 6, and 8 as indicated on the active side of the OPLS-DA scores plot 
(Figure 5B). 
4.4 Bioactivity of isolated compounds 
The isolated bioactive compounds were major metabolites present in the active fractions of Fusarium sp. and Lasiodiplodia 
theobromae. However, not all the predicted bioactive compounds were isolated. The isolated compounds represent 10-15% of 
total predicted active metabolites from both fungi. The isolated compounds 1, 2, 3, and 4 exhibited significant activity against 
T. b. brucei and were comparable to suramin (Table 6). 
Figure 5. (A) Total ion chromatogram of the crude extract of L. theobromae grown in rice media for 15 days (FRC15) (green and red 
represent positive and negative ionisation modes, respectively). Dereplication of numbered peaks is shown on Table 5. (B) OPLS-DA 
scores scatter plot of bioactive vs inactive L. theobromae fractions (R2(Y) = 1.0; Q2 = 0.743; Q2(Y intercept) from permutation test = 
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Among the naphthazarin derivatives, solaniol (4) had the most potent activity against T. b. brucei with an MIC of 0.32 μM as 
also illustrated on the MVA S-plot (Figure 3D) when compared to the other isolated compounds. The next potent compound 
was javanicin (2) with an MIC of 0.60 μM, whereas dihydrojavanicin (3) exhibited less activity (MIC = 1.90 μM). 
Compounds 3 and 4 were the least toxic against PNT2A cells. Meanwhile, anhydrofusarubin (1), had an MIC of 1.20 μM. 
Notably, 1 and 2 showed similar moderate toxic effects against PNT2A cells. Mellein (8) and its derivatives (5-7) also showed 
activity against T. b. brucei, with (−)-5-hydroxymellein (7) possessing slightly higher potency (MIC of 2.40 µM) compared 
with 5, 6 and 8. The naphthazarin derivatives were relatively less toxic than the mellein congeners against PNT2A cells. The 
mellein congeners exhibited moderate toxicity. 
5. CONCLUSION 
The use of metabolomics tools assisted in the decision making which optimum fermentation conditions will be most 
appropriate for production of the bioactive metabolites and which fractions should be prioritized for further isolation work. 
Bioactive molecules were identified and targeted from the crude extracts. Dereplication study was used to screen the bioactive 
metabolites from the crude extracts prior to further scale up or purification work to avoid repetitive work of isolating known 
compounds with the same bioactivity already reported in the literature. The crude extracts obtained from the fungal mycelia 
were preliminarily screened by using HRESI-LCMS for bioactive molecules against T. b. brucei and were analysed by 
multivariate analysis such as PCA and OPLS-DA. Metabolomics and bioassay-guided isolation of potential anti-trypanosomal 
secondary metabolites were identified from the crude extracts of endophytic fungi isolated from the mangrove plant A. lanata, 
which included four naphthazarin-related naphthoquinones, and four dihydroisocoumarins (mellein and three derivatives), in 
which all compounds tested were active against the protozoa, T. b. brucei.  The use of a metabolomics-guided approach has the 
great advantage to predict and target the bioactive metabolites regardless of their respective concentration in a fraction through 
multivariate analysis.  In the conventional approach, isolation work will only be dependent on whatever was perceivable on a 
chromatogram with the risk of isolating the wrong compound that does not match the targeted bioactivity.  The metabolomics 
approach can be a standalone method to target the bioactive compound during the several steps of chromatographic purification 
rather than re-submitting fractions for repetitive bioassay work resulting to loss of the compound. This study established the 
advantage of a metabolomics approach in natural products research for an efficient way to target the bioactive compound of 
interest in chromatographic isolation work. 
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Table 5. List of compounds indicated on the total ion chromatogram for the crude extract of L. theobromae (LTRC15) that were putatively identified using the 
Antimarin and DNP database. Highlighted rows represent compounds predicted to be anti-trypanosomally active by MVA.  Peak IDs used in this table correspond to 


















1 N 1.79 161.0454 162.1410 C6H10O5 pentonic acid γ-lactone 2.2059  Phycomyces blakesleeanus 2.29E+08 
2 N 3.50 181.0507 182.1730 C9H10O4 6-ethyl-2,4-dihydroxybenzoic acid 0.1546  [F] Penicillium baarnense 3.12E+08 




 Botryosphaeria rhodina 
PSU-M35 and PSU-M114 
1.01E+09 
4 P 7.15 231.1592 230.3010 C12H22O4 2,3-dihydroxydodecane-4,7-dione 0.3713 
 Basidiomycete; Conocybe 
siliginea 
5.99E+08 
5 N 7.89 221.0818 222.0891 C12H14O4 asparvenone 1.8459  Aspergillus parvulus 5.02E+08 




1.8471  Aspergillus duricaulis 2.14E+08 
7 N 10.45 333.0770 334.1993 C20H14O5 halenaquinol 1.9427 [P] Xestospongia sapra 7.42E+08 




Porifera; Plakortis aff. 
simplex 
3.57E+08 
9  N 12.45 329.2334 330.4600 C18H34O5 penicitide B 0.1045 Penicillium chrysogenum 3.05E+08 
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11 P 14.97 281.1750 280.3590 C16H24O4 tagetolone 2.9352  Alternaria tagetica 2.29E+08 
12 N 16.16 649.3800 650.3873 C32H58O13 





[B] rhizosphere bacterium; 
Pseudomonas sp. GRP3 
8.56E+08 





[L] Lichens; Acarospora 
gobiensis, Lecanora 
fructulosa, Peltigera 




14 P 19.82 566.4280 565.4208 C31H51N9O viscumamide 1.7923 
 endophytic Paecilomyces 
sp. from mangroves 
1.98E+09 
 
15 N 20.26 295.2278 296.2350 C18H32O3 
12-hydroxy-9Z,13E-octadecadienoic 
acid 
1.4322  Epichloe typhina 4.75E+08 
16 N 22.97 537.3282 538.3355 C31H46N4O2S virenamide A 2.4383 Chordata; Diplosoma virens 1.14E+08 
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Table 6. Activities of the isolated compounds from Fusarium and Lasiodiplodia sp. against T. b. brucei and PNT2A cells. 





% DMSO of 
control  
at 100 μg/mL 
IC50 
(µM) 
1 1.20 67.1 258.6 
2 0.60 61.4 274.4 
3 1.90 22.3 771.3 
4 0.32 38.6 443.0 
5 3.20 82.3 312.9 
6 8.20 87.8 293.3 
7 2.40 89.7 287.1 
8 5.80 84.4 314.6 
suramin 0.11 n.d 258.6 





T. b. brucei 
IC50 
(µg/mL) 
PNT2A cells SIc 
1 0.173 74.48 431 
2 0.089 81.22 915 
3 0.276 223.68 812 
4 0.047 129.36 2769 
5 0.310 60.70 196 
6 0.795 56.90 72 
7 0.233 55.70 239 
8 0.545 59.14 108 
suramin 0.071 n.d  
a Each sample was tested in two independent assays against T. b. brucei, MIC values indicate the minimum inhibitory concentration of a 
compound/standard in μM necessary to achieve 90% growth inhibition. MICs (MIC < 10 μM - promising; 10 μM < MIC > 20 μM - moderate; 
20 μM < MIC > 30 μM - marginal/weak; 30 μM < MIC > 40 μM - limited; MIC > 40 μM - no activity);  
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b Initial screening for cytotoxicity activity against human normal prostatic epithelial cells (PNT2A), % DMSO of control values (at 100 
μg/mL) were determined by averaging of three independent assays results (n=3); c, d Positive controls; n.d.- not determined. 
c Given the IC50 values for the PNT2A cells and for T. b. brucei, the selectivity index (SI) was calculated:     
SI = (IC50 for mammalian cell line / IC50 for protozoan parasite)    
If the IC50 for mammalian cell line PNT2A is > 90 μg/ml, the compound is classified as not cytotoxic. If the IC50 is between 2 and 89 μg/mL, 
the compound is classified as moderately cytotoxic. If the IC50 is < 2 μg/mL, the compound is classified as cytotoxic. This was based on the 
work plans of the Special Programme for Research and Training in Tropical Diseases (TDR), a global programme of scientific collaboration 
that helps facilitate, support and influence efforts to combat diseases of poverty. It is hosted at the World Health Organization (WHO), and is 
sponsored by the United Nations Children’s Fund (UNICEF), the United Nations Development Programme (UNDP), the World Bank and 
WHO. https://www.who.int/tdr/grants/workplans/en/cytotoxicity_invitro.pdf. Accessed 21 May 2019. 
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